<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font23 { font-size : 23; } .font26 { font-size : 26; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">etÂ </span>
   <span class="font26">drug </span>
   <span class="font23">COVID- </span>
   <span class="font19">clinical </span>
   <span class="font18">SARS-CoV- </span>
   <span class="font18">coronavirus </span>
   <span class="font18">treatment </span>
   <span class="font18">viral </span>
   <span class="font17">repurposing </span>
   <span class="font17">patients </span>
   <span class="font16">drugs </span>
   <span class="font16">novel </span>
   <span class="font16">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">disease </span>
   <span class="font15">antiviral </span>
   <span class="font15">receptor </span>
   <span class="font15">studies </span>
   <span class="font14">severe </span>
   <span class="font14">based </span>
   <span class="font14">trials </span>
   <span class="font14">Drug </span>
   <span class="font14">virus </span>
   <span class="font13">associated </span>
   <span class="font13">data </span>
   <span class="font13">including </span>
   <span class="font13">human </span>
   <span class="font13">repurposed </span>
   <span class="font13">respiratory </span>
   <span class="font13">Med. </span>
   <span class="font13">common </span>
   <span class="font13">protease </span>
   <span class="font12">ACE </span>
   <span class="font12">Inhibition </span>
   <span class="font12">SARS-CoV-, </span>
   <span class="font12">development </span>
   <span class="font12">infections </span>
   <span class="font12">promising </span>
   <span class="font12">px; </span>
   <span class="font12">using </span>
   <span class="font12">{font-family </span>
   <span class="font12">COVID-, </span>
   <span class="font12">Discov. </span>
   <span class="font12">Engl. </span>
   <span class="font12">RNA </span>
   <span class="font12">Rev. </span>
   <span class="font12">activity </span>
   <span class="font12">acute </span>
   <span class="font12">addition, </span>
   <span class="font12">approaches </span>
   <span class="font12">cell </span>
   <span class="font12">font-size </span>
   <span class="font12">infection </span>
   <span class="font12">main </span>
   <span class="font12">molecular </span>
   <span class="font12">new </span>
   <span class="font12">number </span>
   <span class="font12">ongoing </span>
   <span class="font12">related </span>
   <span class="font12">therapy </span>
   <span class="font12">use </span>
   <span class="font12">COVID-. </span>
   <span class="font12">Ebola </span>
   <span class="font12">SARS </span>
   <span class="font12">SARS-CoV-. </span>
   <span class="font12">a). </span>
   <span class="font12">agents </span>
   <span class="font12">approved </span>
   <span class="font12">available </span>
   <span class="font12">complementary </span>
   <span class="font12">compounds </span>
   <span class="font12">considered </span>
   <span class="font12">cytokine </span>
   <span class="font12">discovery </span>
   <span class="font12">diseases </span>
   <span class="font12">double; </span>
   <span class="font12">enzyme </span>
   <span class="font12">global </span>
   <span class="font12">laboratory </span>
   <span class="font12">pandemic </span>
   <span class="font12">rate </span>
   <span class="font12">repositioning </span>
   <span class="font12">research </span>
   <span class="font12">target </span>
   <span class="font12">targets </span>
   <span class="font12">â€" </span>
   <span class="font11">(Zhou </span>
   <span class="font11">Accordingly, </span>
   <span class="font11">Infect. </span>
   <span class="font11">Zika </span>
   <span class="font11">[], </span>
   <span class="font11">antibodies </span>
   <span class="font11">approach </span>
   <span class="font11">b). </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cases </span>
   <span class="font11">chloroquine </span>
   <span class="font11">combination </span>
   <span class="font11">computational </span>
   <span class="font11">coronaviruses </span>
   <span class="font11">design </span>
   <span class="font11">disorders </span>
   <span class="font11">efficient </span>
   <span class="font11">inhibitor </span>
   <span class="font11">inhibitors </span>
   <span class="font11">lung </span>
   <span class="font11">pneumonia </span>
   <span class="font11">polymerase </span>
   <span class="font11">results </span>
   <span class="font11">review </span>
   <span class="font11">screening </span>
   <span class="font11">silico </span>
   <span class="font11">solid; </span>
   <span class="font11">success </span>
   <span class="font11">used </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(i.e., </span>
   <span class="font11">Elsevier </span>
   <span class="font11">FigureÂ </span>
   <span class="font11">Health </span>
   <span class="font11">IFN </span>
   <span class="font11">Immunol. </span>
   <span class="font11">Mpro </span>
   <span class="font11">RNA-dependent </span>
   <span class="font11">Virol. </span>
   <span class="font11">Wuhan, </span>
   <span class="font11">account </span>
   <span class="font11">agent </span>
   <span class="font11">alfa </span>
   <span class="font11">angiotensin </span>
   <span class="font11">antibiotic </span>
   <span class="font11">binding </span>
   <span class="font11">biological </span>
   <span class="font11">bold </span>
   <span class="font11">candidate </span>
   <span class="font11">candidates </span>
   <span class="font11">causative </span>
   <span class="font11">centre </span>
   <span class="font11">challenges </span>
   <span class="font11">characteristics </span>
   <span class="font11">courier; </span>
   <span class="font11">crucial </span>
   <span class="font11">drugs, </span>
   <span class="font11">effect </span>
   <span class="font11">em; </span>
   <span class="font11">expression </span>
   <span class="font11">features </span>
   <span class="font11">health </span>
   <span class="font11">help </span>
   <span class="font11">illness </span>
   <span class="font11">immune </span>
   <span class="font11">infected </span>
   <span class="font11">inflammatory </span>
   <span class="font11">information </span>
   <span class="font11">inhibition </span>
   <span class="font11">key </span>
   <span class="font11">known </span>
   <span class="font11">lack </span>
   <span class="font11">methods </span>
   <span class="font11">mild </span>
   <span class="font11">molecule </span>
   <span class="font11">potential </span>
   <span class="font11">previously </span>
   <span class="font11">process </span>
   <span class="font11">production </span>
   <span class="font11">protein </span>
   <span class="font11">pt;} </span>
   <span class="font11">reported </span>
   <span class="font11">resource </span>
   <span class="font11">revealed </span>
   <span class="font11">risk </span>
   <span class="font11">role </span>
   <span class="font11">symptoms </span>
   <span class="font11">syndrome </span>
   <span class="font11">therapeutic </span>
   <span class="font11">time </span>
   <span class="font11">treatment, </span>
   <span class="font11">various </span>
  </p>
 </body>
</html>
